Getting away from glucose: fanning the flames of obesity-induced inflammation
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
The complex processes linking obesity to its deleterious health consequences are finally being unraveled. Inflammation is receiving increased attention for its potential role in the pathogenesis of disorders ranging from insulin resistance and type 2 diabetes (T2D) to steatohepatitis and cardiovascular disease (CVD). Recent back-to-back studies show that obesity perturbs inflammatory gene networks, and hint at causal relationships between inflammation and disease traits associated with the metabolic syndrome. Approaches used in these studies are distinct from classical genome-wide associational studies or tissue-specific mRNA expression profiling, as they rely on ‘neural networks’ and high-powered computational methods to interconnect genetic, genomic and environmental data into a ‘causal’ model. Gene expression was assessed as a quantitative trait to predict which features of obesity promote disease. The first study revealed a tendency towards activation of an inflammation network in adipose tissue of Icelandic subjects with a higher body mass index1. Parallel results were found in the second study, which similarly analyzed adipose tissue and liver from obese and control mice2. A major strength of this approach is that individual state changes can be considered in the context of other changes occurring not only in the tissue being examined, but simultaneously in other tissues, and in the context of genetics, environmental determinants, and even over time. As a word of caution, however, these are early days in systems biology, and findings are limited by the quantity and accuracy of the data used to construct the networks. The relatively unbiased approach used in these studies affirms a role for inflammation in the pathogenesis of metabolic diseases. The approach should also provide new biomarkers for obesity and related metabolic diseases. An additional major promise of such systems biology approaches is in their application to drug discovery. The administration of a drug provides a single perturbation that should influence multiple components of the system. The approach should provide valuable information about mechanisms of action, not only for the drug’s beneficial effects but also for side effects that may limit utility. Identification of new biomarkers for assessing response to a drug should also provide avenues for personalized medicine, by tailoring interventions to an individual’s underlying disease mechanisms. How do these new findings fit the larger, emerging picture of obesity-induced inflammation? Epidemiological evidence relating inflammation to T2D and obesity has existed since the 1950s3, but was not considered in terms of pathogenesis until the 1990s. The list of markers shown to be elevated in obesity includes white blood cell count and plasma concentrations of sialic acid, C-reactive protein (CRP), TNF-α, and IL-6, among other factors3,4, and the list continues to grow. TNF-α was hypothesized to mediate obesity-induced inflammation, because it is produced in adipose tissue and neutralization in mice curbed insulin resistance5. However, TNF-α neutralization trials in humans were negative6, which dampened enthusiasm not only for TNF-α as a drug target in T2D, but for the ‘inflammation hypothesis’ of T2D. New discoveries continued to rekindle interest in this area of investigation despite these ongoing debates. The discovery that obesity also activates intracellular pathways, including IKKβ/NF-κB and JNK7,8, added fuel to the inflammatory hypothesis. Upregulation of the IKKβ/NF-κB axis leads to the excess production of multiple potential mediators of inflammation, whereas JNK activation impinges on insulin signaling through phosphorylation of serine residues of IRS-1. Stimuli potentially activating both IKKβ/NF-κB and JNK in obesity can be separated into extracellular ligands, such as proinflammatory cytokines TNF-α, IL-1β and IL-6 or fatty acids binding to TLRs -- and intracellular stimuli such ER or oxidative stress and ceramides3. Determining which processes initiate obesity-induced inflammation is an active area of investigation. The discovery of macrophages in obese adipose tissue was another milestone towards better understanding obesity-induced inflammation9,10. Macrophages appear to accumulate in obese fat in response to adipocyte stress and death, possibly due to insufficient angiogenesis and hypoxia. Although incompletely understood, the macrophages may participate in the development insulin resistance, T2D and CVD through production of proinflammatory cytokines, chemokines, and other factors. Inhibition of NF-κB or JNK in macrophages improves insulin resistance11,12. Importantly for patients with T2D or CVD, these recent discoveries promise potential new avenues for treatment. Despite the earlier failures with TNF-α blockers, it now appears that inflammation will provide viable therapeutic targets. Two approaches are already being validated in clinical trials, anti-inflammatory salicylates and IL-1 blockade. The salicylates are atypical members of the non-steroidal anti-inflammatory class of drugs, which target NF-κB as opposed to the cyclooxygenase enzymes, Cox1 and Cox2. Salsalate, a salicylate prodrug, has been shown to have glucose lowering efficacy in small trials13, with larger TINSAL-T2D trials ongoing (www.TINSAL-T2D.org). The recombinant IL-1 receptor antagonist anakinra, currently approved for use in rheumatoid arthritis, also improves glycemia in patients with T2D14. IL-1 blockade and salsalate are both likely to improve β cell function and insulin resistance, although anakinra reportedly targets β cells and salsalate effects have focused on insulin sensitivity13,14. While it is too early to say whether salicylate or anakinra will go the distance, these approaches have already served to validate inflammation as a pharmacological target in T2D. Moreover, these approaches are vastly different from one another, as anakinra is an injected biological that binds extracellular IL-1 proteins, whereas salicylate (salsalate) is an orally active small molecule that acts in cells to inhibit transcription. This suggests that numerous nodes or points within inflammation networks may be targeted in diabetes - which is good news, as the therapeutic area of inflammation is rich in molecular targets that have already received great attention from the pharmaceutical industry. Of course salsalate and anakinra target inflammation systemically, while potential targets identified by the back-to-back studies of Schadt and Stefansson and colleagues are restricted to adipose tissue. Unless the studies are expanded to other tissues, which is both feasible and a strength of the approach, the potential targets they identify will be in adipose tissue. Modulation of these targets could have systemic effects and even β cell effects, but this needs to be shown. The authors pointed out that several genes already related to obesity, Zfp90, C3ar1, Hsd11b1 and Tgfbr2, were identified by and thus validated their approach. They also studied 3 additional genes, Lpl, Lactb and Ppm1l, which they identify as “previously unknown obesity genes,” although lipoprotein lipase (Lpl) is certainly well known to researchers in the field. The independent ablation of each of these genes leads to an overweight or obese phenotype. Additional studies will determine whether these are bona fide drug targets or ‘just’ research tools. But it is certain that these types of systems biology, network analysis approaches will prove to be invaluable in the hunt for safer and more efficacious drugs that are tailored to obese subjects and patients with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“inflammation lies at the heart of many of these processes, and pathways involving NF-κB (see e.g. http://www.nf-kb.org/) are especially core here”
From Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples (2010) · cites this paper as Shoelson and Goldfine 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Self-citationA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Self-citationInterleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
IKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Genetics of gene expression and its effect on disease
Emilsson, V., Thorleifsson, G., Zhang, B., Leonardson, A. S., Zink, F., Zhu, J., Carlson, S., Helgason, A., Walters, G. B., Gunnarsdottir, S., et al. (2008) · Nature · doi:10.1038/nature06758 · Cited by 1,296
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,041
Cited by
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
The endocannabinoid system links gut microbiota to adipogenesis
Muccioli, G. G., Naslain, D., Bäckhed, F., Reigstad, C. S., Lambert, D. M., Delzenne, N. M., & Cani, P. D. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.46 · Cited by 691
The gut microbiota, obesity and insulin resistance
Shen, J., Obin, M. S., & Zhao, L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.11.001 · Cited by 599
Diabetes and the Brain: Oxidative Stress, Inflammation, and Autophagy
Muriach, M., Flores-Bellver, M., Romero, F. J., & Barcia, J. M. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/102158 · Cited by 482
Tong, X., Xu, J., Lian, F., Yu, X., Zhao, Y., Xu, L., Zhang, M., Zhao, X., Shen, J., Wu, S., et al. (2018) · mBio · doi:10.1128/mbio.02392-17 · Cited by 378
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“Inflammation and NF-jB As reviewed in the previous survey (Kell 2009a) and else- where (e.g. Shoelson and Goldfine 2009; Shoelson et al. 2007), inflammation lies at the heart of many of these pro- cesses, and pathways involving NF-jB (see e.g. http://www.nf-kb.org/) are especially core here (e.g.…”
BackgroundThe gut microbiome as therapeutic target
Cani, P. D., & Delzenne, N. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.012 · Cited by 350
Poirier, P., Cornier, M.-A., Mazzone, T., Stiles, S., Cummings, S., Klein, S., McCullough, P. A., Ren Fielding, C., & Franklin, B. A. (2011) · Circulation · doi:10.1161/cir.0b013e3182149099 · Cited by 339
Islet Inflammation Impairs the Pancreatic β-Cell in Type 2 Diabetes
Donath, M. Y., Böni-Schnetzler, M., Ellingsgaard, H., & Ehses, J. A. (2009) · Physiology · doi:10.1152/physiol.00032.2009 · Cited by 330
Tzanavari, T., Giannogonas, P., & Karalis, K. P. (2010) · Current Directions in Autoimmunity · doi:10.1159/000289203 · Cited by 322
Geurts, L., Neyrinck, A. M., Delzenne, N. M., Knauf, C., & Cani, P. D. (2014) · Beneficial Microbes · doi:10.3920/bm2012.0065 · Cited by 277
Lecerf, J.-M., Dépeint, F., Clerc, E., Dugenet, Y., Niamba, C. N., Rhazi, L., Cayzeele, A., Abdelnour, G., Jaruga, A., Younes, H., et al. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511007252 · Cited by 262
Inflammation as a Therapeutic Target for Diabetic Neuropathies
Pop-Busui, R., Ang, L., Holmes, C., Gallagher, K., & Feldman, E. L. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0727-5 · Cited by 259
Neuroinflammation and neurodegeneration in overnutrition-induced diseases
Cai, D. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.11.003 · Cited by 256
Nuclear sirtuins and inflammatory signaling pathways
Mendes, K. L., Lelis, D. D. F., & Santos, S. H. S. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.11.001 · Cited by 238
Transcriptional and post-translational regulation of adiponectin
Liu, M., & Liu, F. (2010) · Biochemical Journal · doi:10.1042/bj20091045 · Cited by 235
Harte, A. L., Varma, M. C., Tripathi, G., McGee, K. C., Al-Daghri, N. M., Al-Attas, O. S., Sabico, S., O’Hare, J. P., Ceriello, A., Saravanan, P., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1593 · Cited by 235
Cytokine production by islets in health and diabetes: cellular origin, regulation and function
Donath, M. Y., Böni-Schnetzler, M., Ellingsgaard, H., Halban, P. A., & Ehses, J. A. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.12.010 · Cited by 227
Ehses, J. A., Meier, D. T., Wueest, S., Rytka, J., Boller, S., Wielinga, P. Y., Schraenen, A., Lemaire, K., Debray, S., Van Lommel, L., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1747-3 · Cited by 222
Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB
Purkayastha, S., Zhang, G., & Cai, D. (2011) · Nature Medicine · doi:10.1038/nm.2372 · Cited by 220
Fuentes, E., Fuentes, F., Vilahur, G., Badimon, L., & Palomo, I. (2013) · Mediators of Inflammation · doi:10.1155/2013/136584 · Cited by 208
Tian, J., Dang, H. N., Yong, J., Chui, W.-S., Dizon, M. P. G., Yaw, C. K. Y., & Kaufman, D. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025338 · Cited by 198
Wu, L., Parekh, V. V., Gabriel, C. L., Bracy, D. P., Marks-Shulman, P. A., Tamboli, R. A., Kim, S., Mendez-Fernandez, Y. V., Besra, G. S., Lomenick, J. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200498109 · Cited by 190
Inflammatory cause of metabolic syndrome via brain stress and NF-κB
Cai, D., & Liu, T. (2012) · Aging · doi:10.18632/aging.100431 · Cited by 189
Purkayastha, S., Zhang, H., Zhang, G., Ahmed, Z., Wang, Y., & Cai, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006875108 · Cited by 179
Role of intestinal inflammation as an early event in obesity and insulin resistance
Ding, S., & Lund, P. K. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283478727 · Cited by 165
Neuroinflammatory basis of metabolic syndrome
Purkayastha, S., & Cai, D. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.09.005 · Cited by 144
Hypothalamic inflammation: a double‐edged sword to nutritional diseases
Cai, D., & Liu, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06388.x · Cited by 159
Lindholm, C. R., Ertel, R. L., Bauwens, J. D., Schmuck, E. G., Mulligan, J. D., & Saupe, K. W. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-012-0199-2 · Cited by 136
“To determine whether a systemic inflammatory response was present in the HFD group, as often occurs during obesity [47, 48, 57], the serum concentrations of TNF-α and IL-6 were measured via ELISA.”
MethodAdipose Tissue Vascularization: Its Role in Chronic Inflammation
Ye, J. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0183-1 · Cited by 109
Cani, P. D. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03866.x · Cited by 128
Sheng, L., Zhou, Y., Chen, Z., Ren, D., Cho, K. W., Jiang, L., Shen, H., Sasaki, Y., & Rui, L. (2012) · Nature Medicine · doi:10.1038/nm.2756 · Cited by 117
Action LADA Study Group, Pham, M. N., Hawa, M. I., Pfleger, C., Roden, M., Schernthaner, G., Pozzilli, P., Buzzetti, R., Scherbaum, W. A., Seißler, J., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2088-6 · Cited by 113
Diabetes mellitus and pancreatitis – cause or effect?
Davison, L. J. (2015) · Journal of Small Animal Practice · doi:10.1111/jsap.12295 · Cited by 101
Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients
Gerdes, S., Pinter, A., Papavassilis, C., & Reinhardt, M. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16004 · Cited by 97
Role of PPARs in inflammatory processes associated with metabolic syndrome (Review)
Fuentes, E., Guzmán, L., Moore‐Carrasco, R., & Palomo, I. F. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1714 · Cited by 94
Current and Future Drug Targets in Weight Management
Witkamp, R. F. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0341-1 · Cited by 90
Klimčáková, E., Roussel, B., Kovacova, Z., Kováčiková, M., Šiklová, M., Combes, M., Hejnová, J., Decaunes, P., Maoret, J.-J., Vedral, T., et al. (2011) · Diabetologia · doi:10.1007/s00125-010-2014-3 · Cited by 80
Elabd, E. M. Y., McGee, K. C., Tripathi, G., Al‐Daghri, N. M., Abdalla, M. S., Sharada, H. M., Ashour, E., Amin, A. I., Ceriello, A., O’Hare, J. P., et al. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.11.003 · Cited by 80
Bakkar, N. Z., Dwaib, H. S., Fares, S. A., Eid, A. H., Al-Dhaheri, Y., & EL‐Yazbi, A. F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239005 · Cited by 79
Andersson, U., Berger, K., Högberg, A., Landin‐Olsson, M., & Holm, C. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.203 · Cited by 73
Ullah, R., Rauf, N., Nabi, G., Shen, Y., Yu-Dong, Z., & Fu, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112012 · Cited by 72
Lack of association between body mass index and plasma adiponectin levels in healthy adults
Kuo, S.-M., & Halpern, M. M. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.20 · Cited by 69
Hepatic TRAF2 Regulates Glucose Metabolism Through Enhancing Glucagon Responses
Chen, Z., Sheng, L., Shen, H., Zhao, Y., Wang, S., Brink, R. A., & Rui, L. (2012) · Diabetes · doi:10.2337/db11-0474 · Cited by 58
Update on Biomarkers of Chronic Inflammatory Processes Underlying Diabetic Neuropathy
Stoian, A., Muntean, C., Babă, D.-F., Manea, A., Dénes, L., Simon-Szabó, Z., Kosovski, I.-B., Nemes-Nagy, E., Gliga, F. I., & Stoian, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910395 · Cited by 54
Bone marrow-CNS connections: Implications in the pathogenesis of diabetic retinopathy
Douglas, J. Y., Bhatwadekar, A. D., Calzi, S. L., Shaw, L. C., Carnegie, D., Caballero, S., Li, Q., Stitt, A. W., Raizada, M. K., & Grant, M. B. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.04.005 · Cited by 54
Li, S., Kievit, P., Robertson, A.-K., Kolumam, G. A., Li, X.-M., von Wachenfeldt, K. A., Valfridsson, C., Bullens, S., Messaoudi, I., Bader, L., et al. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.06.001 · Cited by 52
Osto, M., Zini, E., Reusch, C. E., & Lutz, T. A. (2012) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2012.11.019 · Cited by 51
Low-grade inflammation in overweight and obese adults is affected by weight loss program
Petelin, A., Bizjak, M., Černelič-Bizjak, M., Jurdana, M., Jakus, T., & Pražnikar, Z. J. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0102-9 · Cited by 49
An eicosanoid-centric view of atherothrombotic risk factors
Gleim, S., Stitham, J., Tang, W. H., Martin, K. A., & Hwa, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0982-9 · Cited by 48
Neuroimmune communication in hypertension and obesity: A new therapeutic angle?
de Kloet, A. D., Krause, E. G., Shi, P. D., Zubcevic, J. A., Raizada, M. K., & Sumners, C. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.02.005 · Cited by 47
Lee, M., Zhao, H., Liu, X., Liu, D., Chen, J., Li, Z., Chu, S., Kou, X., Liao, S., Deng, Y., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7805393 · Cited by 47
Metabolic Syndrome and Neuroprotection
Etchegoyen, M., Nobile, M. H., Báez, F., Posesorski, B., González, J., Lago, N. R., Milei, J., & Losada, M. E. O. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00196 · Cited by 46
Chen, Z., Shen, H., Sun, C., Yin, L., Tang, F., Zheng, P., Liu, Y., Brink, R. A., & Rui, L. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00470.2014 · Cited by 43
Cho, K. W., Zhou, Y., Sheng, L., & Rui, L. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00459-10 · Cited by 42
Cortez‐Pinto, H., Borralho, P., Machado, J., Lopes, T., do Gato, I. V., Santos, A. M., & Guerreiro, A. S. (2016) · GE Portuguese Journal of Gastroenterology · doi:10.1016/j.jpge.2016.01.004 · Cited by 42
Hypothalamic and inflammatory basis of hypertension
Khor, S., & Cai, D. (2017) · Clinical Science · doi:10.1042/cs20160001 · Cited by 42
Functional and Muscular Adaptations in an Experimental Model for Isometric Strength Training in Mice
Krüger, K., Geßner, D. K., Seimetz, M., Banisch, J., Ringseis, R., Eder, K., Weißmann, N., & Mooren, F. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079069 · Cited by 40
Inflammatory biomarkers as a part of diagnosis in diabetic peripheral neuropathy
Sai Laxmi, M., & Orsu, P. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00734-1 · Cited by 38
Kaabi, Y. A. (2022) · Molecules · doi:10.3390/molecules27217352 · Cited by 37
Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
Chen, Z., Canet, M. J., Sheng, L., Jiang, L., Xiong, Y., Yin, L., & Rui, L. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.09.013 · Cited by 35
Small intestine remodeling in male Goto–Kakizaki rats
Pereira, J. N. B., Murata, G. M., Sato, F. T., Marosti, A. R., Carvalho, C. R. D. O., & Curi, R. (2021) · Physiological Reports · doi:10.14814/phy2.14755 · Cited by 32
Lipocalin 13 regulation of glucose and lipid metabolism in obesity
Zhou, Y., & Rui, L. (2013) · Vitamins & Hormones · doi:10.1016/b978-0-12-407766-9.00015-8 · Cited by 28
“Obesity is also associated with chronic, low-grade inflammation, particularly in adipose tissues and the liver, and proinflammatory cytokines further exacerbate insulin resistance (Hotamisligil, 2006; Shoelson and Goldfine, 2009; Tarantino et al., 2007; Taube et al., 2009).”
BackgroundIncretin hormones as immunomodulators of atherosclerosis
Alonso, N., Julián, M. T., Puig‐Domingo, M., & Vives‐Pi, M. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00112 · Cited by 25
Chiadak, J. D., Arsenijevic, T., Verstrepen, K., Grégoire, F., Bolaky, N., Delforge, V., Flamand, V., Perret, J., & Delporte, C. (2016) · Mediators of Inflammation · doi:10.1155/2016/1431789 · Cited by 25
Fishing Out a Sensor for Anti-inflammatory Oils
Saltiel, A. R. (2010) · Cell · doi:10.1016/j.cell.2010.08.022 · Cited by 22
Neuroinflammation in Overnutrition-Induced Diseases
Cai, D. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00008-0 · Cited by 22
ERAPSO: Revealing the High Burden of Obesity in German Psoriasis Patients
Schwarz, P. E. H., Pinter, A., Melzer, N., Barteczek, P., & Reinhardt, M. (2019) · Dermatology and Therapy · doi:10.1007/s13555-019-0314-1 · Cited by 20
Chakrabarti, A., Membrez, M., Morin‐Rivron, D., Siddharth, J., Chou, C. J., Henry, H., Bruce, S., Métairon, S., Raymond, F., Bétrisey, B., et al. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0033-0 · Cited by 20
The Gut Microbiome and Metabolic Health
Francino, M. P. (2017) · Current Nutrition Reports · doi:10.1007/s13668-017-0190-1 · Cited by 19
Role of physical activity in cardiovascular disease prevention in older adults
Lillo, N., Vélez, G. F. P., Fuentes, E., & Palomo, I. F. (2015) · Sport Sciences for Health · doi:10.1007/s11332-015-0233-1 · Cited by 16
Kоrsakova, Y. L., Korotaeva, T. V., Loginova, Е. Y., Gubar, Е. Е., Алексеевна, В. Е., Vasilenko, A., Kuznetsova, N. A., Михайловна, П. И., & Nasonov, E. L. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.05.200789 · Cited by 15
Liu, R., Wei, N., Guo, W., Qiang, O., Li, X., Ou, Y., Huang, W., & Tang, C. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0413-6 · Cited by 14
Han, F., Li, G., Dai, S., & Huang, J. (2015) · Molecular BioSystems · doi:10.1039/c5mb00480b · Cited by 14
Benefits of bariatric surgery: an issue of microbial–host metabolism interactions?
Cani, P. D., & Delzenne, N. M. (2011) · Gut · doi:10.1136/gut.2011.242503 · Cited by 13
Gut Microbiota, Obesity and Metabolic Dysfunction
Meiliana, A., & Wijaya, A. (2011) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v3i3.147 · Cited by 9
Integrated network systems and evolutionary developmental endocrinology
Koshiyama, H., Ogawa, Y., Tanaka, K., & Tanaka, I. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.07.028 · Cited by 8
Al-Saidi, A., AlZaim, I., Hammoud, S. H., Arab, G. A., Abdalla, S., Mougharbil, N., Eid, A. H., & EL‐Yazbi, A. F. (2024) · Clinical Science · doi:10.1042/cs20231186 · Cited by 7
Evaluation of laboratory findings indicating pancreatitis in healthy lean, obese, and diabetic cats
Jørgensen, F. K., Bjørnvad, C. R., Krabbe, B., Nybroe, S., & Kieler, I. N. (2024) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.17236 · Cited by 6
Metabolic Syndrome as a Risk Factor for Alzheimer Disease
Farooqui, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7318-3_8 · Cited by 5
Appetite Regulation and Thermogenesis
Maratos–Flier, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00025-1 · Cited by 5
The Immune System and Inflammation in Type 2 Diabetes
Macedo, R. G. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_11 · Cited by 4
Krumbeck, J. A. (2016) · Lincoln (University of Nebraska) · Cited by 3
Zhang, L., Cui, Y., Fu, F., Li, Z., Pan, X., Li, H., & Li, L. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2909 · Cited by 3
A dietary interventional study moderating fat intake in Saudi subjects with metabolic disease
Aldesi, D. A. D. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33686212 · Cited by 3
Adipose Tissue Biology: An Update Review
Meiliana, A., & Wijaya, A. (2009) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v1i3.98 · Cited by 2
Nutritional interventions focusing on gastrointestinal and metabolic health
Salden (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170317bs · Cited by 2
Lee, M., Tan, Y., Li, H.-L., Liu, D., & Zhao, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1675295 · Cited by 1
Effects of Long Term Consumption of High Calorie Diet on Neurological Disorders
Farooqui, A. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-15254-7_9 · Cited by 1
Appetite Regulation and Thermogenesis
Maratos–Flier, E. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00027-7 · Cited by 1
Nutritional Programming of Probiotics to Promote Health and Well-Being
Moscovici, A., & Lesmes, U. (2012) · InTech eBooks · doi:10.5772/50051 · Cited by 1
Sri, L., & Orsu, P. (2023) · International Journal of Pharmaceutical Sciences and Nanotechnology · doi:10.37285/ijpsn.2023.16.2.5 · Cited by 1
Obesidade: um enfoque na inflamação periférica e central
Fróes, F. T. (2012) · Lume (Universidade Federal do Rio Grande do Sul) · Cited by 1
Al-Shahwani, R. M. S. (2012) · Cited by 1
Pham, R. N., & Do, T. M. N. (2011) · Univ. Duesseldorf: Duesseldorfer Dokumenten- und Publikationsserver
The role of endoplasmic reticulum in human adipose tissue
Alhusaini, S. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33602866
Factors of Inflammation in Haitian Americans and African Americans with and without Type 2 Diabetes
Antwi, J. (2014) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fi14110719
Lois, K. B. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33674554
Ding, X., Yuan, H., Gu, R., Gao, Y., Liu, X., & Gao, Y. (2016) · International Journal of Endocrinology · doi:10.1155/2016/8597085
Bundalo, M. (2016) · VinaR (Institute of Nuclear Sciences "Vinča")
Metadata
- Authors
- Shoelson, S. E., & Goldfine, A. B.
- Affiliations
- Joslin Diabetes Center (US)
- Venue
- Nature Medicine
- Published
- 2009-04
- Volume
- 15
- Issue
- 4
- Pages
- 373-374
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC4097148
- OpenAlex
- W2062840218
- Cited by
- 98
- References
- 14
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 4 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 4 · 2015: 7 · 2014: 4 · 2013: 11 · 2012: 18
- FWCI
- 10.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5p50hl083813-05)
- National Heart, Lung, and Blood Institute (P50-HL083813)
- National Institute of Diabetes and Digestive and Kidney Diseases (RC4DK090792, U01DK074556, R01DK095327, R01DK045943, R01DK051729, R37DK051729, R01DK073547, R01DK043123, P30DK036836)
- National Center for Research Resources (M01RR001032, M01RR002635)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
- Keywords
- obesity, inflammation, glucose, obesity-associated inflammation
- MeSH terms
- Adipose Tissue, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Fatty Liver, Humans, Inflammation, Insulin Resistance, Obesity, Gene Expression, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.